Effects of Orlistat or Telmisartan on the Serum Free Fatty Acids in Non-alcoholic Fatty Liver Disease Patients: An Open-Labeled Randomized Controlled Study

Vian Ahmed Wasta Esmail, Marwan S.M. Al-Nimer, Mohammed Omer Mohammed

Open source

DOI
10.5152/tjg.2020.19365
Published
2022-05-15
Container
Turkish Journal of Gastroenterology
Publisher
AVES YAYINCILIK A.Ş.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5152/tjg.2020.19365,
  title = {Effects of Orlistat or Telmisartan on the Serum Free Fatty Acids in Non-alcoholic Fatty Liver Disease Patients: An Open-Labeled Randomized Controlled Study},
  author = {Vian Ahmed Wasta Esmail and Marwan S.M. Al-Nimer and Mohammed Omer Mohammed},
  year = {2022},
  journal = {Turkish Journal of Gastroenterology},
  doi = {10.5152/tjg.2020.19365},
  url = {https://doi.org/10.5152/tjg.2020.19365}
}

RIS

TY  - JOUR
TI  - Effects of Orlistat or Telmisartan on the Serum Free Fatty Acids in Non-alcoholic Fatty Liver Disease Patients: An Open-Labeled Randomized Controlled Study
AU  - Vian Ahmed Wasta Esmail
AU  - Marwan S.M. Al-Nimer
AU  - Mohammed Omer Mohammed
PY  - 2022
JO  - Turkish Journal of Gastroenterology
DO  - 10.5152/tjg.2020.19365
UR  - https://doi.org/10.5152/tjg.2020.19365
ER  - 

APA

Esmail, V. A. W., Al-Nimer, M. S., & Mohammed, M. O. (2022). Effects of Orlistat or Telmisartan on the Serum Free Fatty Acids in Non-alcoholic Fatty Liver Disease Patients: An Open-Labeled Randomized Controlled Study. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2020.19365

Source records